đź“‹ FDA Reference
syngo rt interface
Siemens Medical Solutions U
Summary: The syngo rt interface by Siemens Medical Solutions U is a medical device used for interfacing with radiotherapy systems, primarily in oncology settings. It is utilized by radiation oncologists and medical physicists.
FDA Clearance Information
Pathway
510K
Number
K120363 ↗
Decision Date
March 20, 2012
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The syngo rt interface was cleared through the FDA 510(k) pathway on March 20, 2012. It is manufactured by Siemens Medical Solutions U and classified as a Class 2 device under product code MUJ.
What It Is
The syngo rt interface is a software platform designed to integrate and manage data between imaging systems and radiotherapy treatment devices. It facilitates the planning and delivery of radiation therapy by ensuring precise data transfer and synchronization. This interface is crucial for optimizing treatment accuracy and efficiency in oncology care.
Clinical Applications
The syngo rt interface is commonly used in radiation oncology departments, where it aids in the planning and execution of radiotherapy for cancer patients. It is particularly valuable in settings that require precise tumor targeting, such as in the treatment of glioblastoma and other solid tumors. The device supports clinicians in ensuring that radiation doses are accurately delivered to the intended anatomical sites.
Indications for Use
The syngo rt interface is indicated for use in the management of radiotherapy data, particularly for tumor ablation and dialysis access procedures. It is designed to support clinicians in delivering precise and effective radiation therapy for cancer treatment.
Practical Considerations
The syngo rt interface is compatible with various radiotherapy systems and requires integration with existing imaging and treatment planning software. Clinicians should ensure that their systems are compatible and may need to undergo training to maximize the device's capabilities.
Related Literature
The linked study titled 'Quality control of 3D MRSI data in glioblastoma' explored the use of automatic quality control for magnetic resonance spectroscopic imaging data using random forest analysis. The study found that automatic QC could potentially replace manual inspection, which is subjective and time-consuming. However, the study was limited by its focus on a single tumor type and the need for further validation in diverse clinical settings.
Frequently Asked Questions
What is syngo rt interface used for?
The syngo rt interface is used for integrating and managing data between imaging and radiotherapy systems to ensure precise radiation therapy delivery.
What specialties typically use this device?
Radiation oncologists and medical physicists typically use this device in oncology settings.
What are the FDA-cleared indications?
The device is cleared for managing radiotherapy data, particularly in tumor ablation and dialysis access procedures.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.